Aeterna Zentaris
AEZS
#10766
Rank
A$26.45 M
Marketcap
A$8.64
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$3.10. In 2022 the company made an earnings per share (EPS) of A-$7.07 a decrease over its 2021 EPS that were of A-$2.75.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$7.07157.14%
2021A-$2.75-41.48%
2020A-$4.70-64.46%
2019A-$13.22-240%
2018A$9.44-122.32%
2017A-$42.30-53.53%
2016A-$91.03-86.71%
2015A-$685.15-35.21%
2014A-$1,058-216.67%
2013A$906.48-123.3%
2012A-$3,890-40.8%
2011A-$6,572-6.45%
2010A-$7,025-27.91%
2009A-$9,745-61.61%
2008A-$25,38183.61%
2007A-$13,824-195.31%
2006A$14,504178.26%
2005A$5,212-330%
2004A-$2,266-80.05%
2003A-$11,35917.78%
2002A-$9,645515.93%
2001A-$1,566-68.6%
2000A-$4,987119.62%
1999A-$2,271-3.63%
1998A-$2,356

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.93-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$2.99-196.66%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.83-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.54-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$5.32-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA